BAP1 and neoplasm: A recently published study has shown that the heterozygous germline BAP1 mutations (BAP1+/−) induce cell metabolic changes linked to the increase aerobic glycolysis, leading to reprogramming of the activities that create a favorable environment to carcinogenesis and tumor growth (52).